Smith et al. (2017) tested this concept by developing a biopolymer scaffold that delivered CAR-T cells and cyclic di-GMP, a stimulator of interferon genes (STING) agonist, directly at the tumor site to efficiently mediate tumor regression and induce a broader immune response in mouse models of solid tumors [160]. The gene discussed is STING1; the disease is neoplasm.